600352.SS

The company maintains a debt-to-equity ratio of 0.7 and a current ratio of 1.33, indicating moderate liquidity risk. With a price-to-book ratio of 1.16 and a market cap of 37.9 billion CNY, the stock trades at a slight premium to its book value. The company's return on equity of 5.6% and return on assets of 2.43% suggest relatively modest profitability compared to capital-intensive industry peers. The company's operating margin of 17.7% (calculated from operating income of 2.35 billion CNY on revenue of 13.31 billion CNY) and net margin of 13.7% (1.83 billion CNY net income) position it near the median for specialty chemicals firms. Free cash flow of 904 million CNY represents 3.7% of revenue, which is in line with industry norms for mid-sized chemical producers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of segment and geographic diversification increases exposure to regional demand fluctuations and regulatory changes. Analyst price targets range from 17.01 CNY to 21.52 CNY, with a mean of 19.27 CNY, implying a potential 65% upside from the current market price of 11.65 CNY. The company's revenue growth trajectory remains unquantified in the available data, but the mean recommendation of 1.67 (strong buy to buy range) suggests positive near-term expectations. The risk assessment identifies liquidity as a medium concern, with net cash (12.26 billion CNY cash minus 22.8 billion CNY long-term debt) showing a negative position of 10.54 billion CNY. Dilution risk is assessed as low, with no recent share issuance activity and identical basic and diluted share counts of 3.25 billion. No recent filings or transcripts are available in the source data to identify material events affecting the company's operations or strategy.